Gilead Sciences
Search results
We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. 13th Largest Pharma Company in India, In terms of Domestic Sales for MAT September 2023
Get all the information on Emcure Pharmace with historic price charts for NSE / BSE. Experts & Broker view also get the Emcure Pharmace Ltd. buy/sell tips detailed news, announcements,...
Emcure Pharmaceuticals Limited Stock Price Today, Live NSE Share Price: Get the latest Emcure Pharmaceuticals Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Incorporated in 1981, Emcure Pharmaceuticals Limited is an Indian company that develops, manufactures, and markets a wide range of pharmaceutical products globally across several major therapeutic areas.
Sanjay Rajanikant Mehta President, Emerging Markets. Tajuddin Sabir Shaikh Chief Financial Officer. Prakash Kumar Guha Managing Director (MD) - Zuventus Healthcare Limited. Deepak Gondaliya President – Technical Operations. Sanjay Singh Chief Executive Officer & Whole-time Director – Gennova Biopharmaceuticals Limited.
Jul 2, 2024 · Get Emcure Pharmaceuticals latest Yearly Results, Financial Statements and Emcure Pharmaceuticals detailed profit and loss accounts.
Emcure Pharma has an established presence in international markets, which it believes is a solid complement to its domestic business and presents substantial opportunities for growth. The company sells its portfolio of products internationally in over 70 countries, with Europe and Canada currently being its primary international markets.
Emcure Pharma's IPO saw strong investor interest, with oversubscription rates of 67.87 times. Post-listing, shares rose 4.5% to Rs. 1384, reflecting confidence in the company's future.
4 days ago · Emcure Pharmaceuticals Ltd is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas. It offers a range of products and services under formulations, biologics, and Active Pharmaceutical Ingredients (APIs). It focuses on various key therapeutic areas, such as gynecology, cardiology, anti-infective, diabetes, biologics, mRNA vaccines, and vitamin, minerals and nutrients.
Emcure Pharmaceuticals shares made a strong debut today (July 10) after listing at ₹1,325.05. This marks a premium of 31.5 per cent over the issue price of ₹1,008. The IPO opened on July 3 and ...
